The sweeping collaboration is specifically engineered to accelerate growth within India’s rapidly expanding specialty food and pharmaceutical ingredient markets.
Ingredion has proposed a £2.74 billion takeover of Tate & Lyle, aiming to expand its global food ingredient solutions and specialty product portfolio.
Net sales declined about 1% year over year, while reported and adjusted operating income decreased 26% and 22%, respectively, versus Q1 2025.
The move reunites the chief executive and board chair roles after a period in which the positions were held separately, with Gregory B. Kenny stepping down as non executive chairman while remaining on the board.
The company posted strong fourth-quarter and full-year 2025 financial results, reflecting improved profitability across its global ingredient portfolio.